Prostate Cancer
Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial.
September 8, 2023
Quality rectal hydrogel placement allows for gel-enabled dose-escalated EBRT (GEDE-EBRT) without rectal interference in prostate cancer.
September 7, 2023
State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature.
September 7, 2023
Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients.
September 7, 2023
JNM Publishes Consensus Statement on Patient Selection and Appropriate Use of Lu-177 PSMA-617 Radionuclide Therapy
September 6, 2023
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
September 6, 2023
Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.
September 6, 2023
Androgen deprivation therapy in localized prostate cancer. Current status and future trends.
September 6, 2023
SpaceOAR hydrogel distribution and early complications in patients undergoing radiation therapy for prostate cancer.
September 5, 2023
Barrigel Spacer Injection Technique.
September 5, 2023
Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases.
September 5, 2023
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer.
September 5, 2023